Quality of life of elderly patients receiving weekly carboplatin and paclitaxel chemotherapy plus cetuximab first line for metastatic squamous cell carcinoma of the head and neck

被引：0
|
作者：
Lugini, A. [1 ]
Rossi, R. [2 ]
Pace, R. [1 ]
Rauco, A. [1 ]
Santarelli, M. [3 ]
Capparella, V. [1 ]
机构：
[1] San Camillo Lellis, Med Oncol Unit, Rieti, Italy
[2] Santa Maria Goretti, Med Oncol Unit, Rieti, Italy
[3] San Camillo Lellis, Radiotherapy Unit, Rieti, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3176
引用
收藏
页码：S752 / S752
页数：1
相关论文
共 50 条
  • [1] Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Mesia, R.
    Rivera, F.
    Kawecki, A.
    Rottey, S.
    Hitt, R.
    Kienzer, H.
    Cupissol, D.
    De Raucourt, D.
    Benasso, M.
    Koralewski, P.
    Delord, J. -P.
    Bokemeyer, C.
    Curran, D.
    Gross, A.
    Vermorken, J. B.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (10) : 1967 - 1973
  • [2] Induction chemotherapy (CT) with weekly paclitaxel, carboplatin, and cetuximab for squamous cell carcinoma of the head and neck (HN).
    Kies, M. S.
    Garden, A. S.
    Holsinger, C.
    Papadimitrakopoulou, V.
    El-Naggar, A. K.
    Gillaspy, K.
    Lewin, J.
    Lu, C.
    Villalobos, S.
    Glisson, B. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 285S - 285S
  • [3] Weekly Cetuximab and Paclitaxel for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Fushimi, Chihiro
    Baba, Daisuke
    Masubuchi, Tatsuo
    Yamazaki, Morio
    Kitani, Yosuke
    Kitajima, Tatsuya
    Tanaka, Junpei
    Hanyu, Kenji
    Tanaka, Naruhisa
    Miura, Kouki
    Tada, Yuichiro
    [J]. IN VIVO, 2020, 34 (05): : 2653 - 2657
  • [4] Weekly paclitaxel and carboplatin combination chemotherapy in patients with advanced squamous cell carcinoma of the head and neck
    Moosmann, P
    Egli, F
    Stahel, RA
    Jost, L
    [J]. ONKOLOGIE, 2003, 26 (06): : 568 - 572
  • [5] Activity of weekly paclitaxel−cetuximab chemotherapy in unselected patients with recurrent/metastatic head and neck squamous cell carcinoma: prognostic factors
    I. Pajares Bernad
    J. Martínez Trufero
    L. Calera Urquizu
    R. A. Pazo Cid
    A. Cebollero de Miguel
    M. J. Agustin
    M. Lanzuela
    A. Antón
    [J]. Clinical and Translational Oncology, 2017, 19 : 769 - 776
  • [6] Weekly paclitaxel, carboplatin and cetuximab (PCC) as first-line treatment of recurrent and/or metastatic head & neck squamous cell carcinoma (R/M-HNSCC) for patients ineligible to cisplatin based chemotherapy
    Carinato, H.
    Burgy, M.
    Fischbach, C.
    Kalish-Weindling, M.
    Pabst, L.
    Frasie, V.
    Thiery, A.
    Coliat, P.
    Demarchi, M. F.
    Petit, T.
    Borel, C.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S668 - S668
  • [7] Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60 Patients
    Carinato, Helene
    Burgy, Mickael
    Ferry, Regine
    Fischbach, Cathie
    Kalish, Michal
    Guihard, Sebastien
    Brahimi, Youssef
    Flesch, Henri
    Bronner, Guy
    Schultz, Philippe
    Frasie, Veronique
    Thiery, Alicia
    Demarchi, Martin
    Petit, Thierry
    Jung, Alain C.
    Wagner, Pierre
    Coliat, Pierre
    Borel, Christian
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] CARBOPLATIN, PACLITAXEL AND PEMBROLIZUMAB FOR THE FIRST LINE TREATMENT OF RECURRENT AND/OR METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA
    Valadez, Angelica
    Welsh, Madeleine
    Kim, Christine
    Johns, Angela
    Algazi, Alain
    Kang, Hyunseok
    Kang, Hyunseok
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A118 - A118
  • [9] Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck
    Hitt, R.
    Irigoyen, A.
    Cortes-Funes, H.
    Grau, J. J.
    Garcia-Saenz, J. A.
    Cruz-Hernandez, J. J.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 (04) : 1016 - 1022
  • [10] WEEKLY REGIMEN OF PACLITAXEL-CARBOPLATIN-CETUXIMAB AS FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH PLATINUM-RESISTANT RECURRENT OR METASTATIC SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SSCHN): RESULTS OF A PHASE II STUDY
    Rozzi, A.
    Lenci, G.
    Corona, M.
    Nardoni, C.
    Restuccia, M. R.
    Falbo, T.
    Nappa, M.
    Costa, A. M.
    Spigone, B.
    Lanzetta, G.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 323 - 323
12345